NCT04364022View on ClinicalTrials.gov

Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland

PHASE3CompletedINTERVENTIONAL

Enrollment

326

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

March 24, 2021

Study Completion Date

March 24, 2021

Conditions

Prevention of COVID-19

Interventions

DRUG

Lopinavir/ritonavir

2x 200mg/50mg, twice daily for 5 days (bid, PO)

Trial Locations (4)

Unknown

Instituto Nacional de Infectiologia Evandro Chagas, Fiocruz, Rio de Janeiro

Universitätsspital Basel and SwissTPH, Basel

Hôpitaux Universitaires de Genève, Geneva

Ospedale Regionale di Lugano, Lugano

All Listed Sponsors

lead

Calmy Alexandra

OTHER

NCT04364022 - Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland | Biotech Hunter | Biotech Hunter